Association of tamoxifen resistance and lipid reprogramming in breast cancer
Susanne Hultsch(Institute for Biomedicine), Olli Kallioniemi(University of Helsinki)
Cited by 217
Related Papers
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
|Genome biology|2011|328
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
|Molecular Oncology|2012|93
A cell spot microarray method for production of high density siRNA transfection microarrays
|BMC Genomics|2011|58
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
|British Journal of Cancer|2022|25
Seven shades of tamoxifen resistance : Molecular mechanisms of drug resistance in breast cancer
|Työväentutkimus Vuosikirja|2018|1